In 2015, the research conducted by Cai et al found that 67 of 95 (70.5%) patients had high FASN expression in the tumor cell cytoplasm and tended to have worse overall survival rates (Memarzadeh et al., 2003; Cai et al., 2015). Here, FASN is linked to neoplasm.